160 / 185
160
Diretrizes 2013
and mortality after smoking cessation: status of the
evidence. Eur Respir J. 2008;32(4):844-53.
114. Selifkoff IJ, Hammond EC, Seidman H.
Mortality experience of insulation workers in the
United States and Canada, 1943-1976. Ann NY Acad
Sci. 1979;330:91-116.
115. Joseph AM, Norman SM, Ferry LH, Prochazka
AV, Westman EC, Steele BG, et al. The safety of
transdermal nicotine as an aid to smoking cessation
in patients with cardiac disease. N Engl J Med.
1996;335(24):1792-8.
116. Bhatnagar A. Environmental cardiology:
studying mechanistic links between pollution and
heart disease. Circ Res. 2006;99(7):692-705.
117. Ludvig J, Miner B, Eisenberg MJ. Smoking
cessation in patients with coronary artery disease.
Am Heart J. 2005;149(4):565-72.
118. Tonstad S, Farsang C, Klaene G, Lewis K,
Manolis A, Perruchoud AP, et al. Bupropion SR for
smoking cessation in smokers with cardiovascular
disease: a multicentre, randomised study. Eur Heart
J. 2003;24(10):946-55.
119. Teo KK, Ounpuu S, Hawken S, Pandey MR,
Valentin V, Hunt D, et al. Tobacco use and risk of
myocardial infarction in 52 countries in the
INTERHEART study: a case-control study. Lancet.
2006;368(9536):647-58.